FRONTEO,Inc. (2158.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

52.4x

EV/EBITDA

22.7x

Market Cap

JPY 24.09B

MomentumView details →

1D Return

−0.33%

YTD Return

−28.52%

RSI (14)

46.6

ValuationView details →

P/E (Fwd)

52.4x

EV/EBITDA

22.7x

Market Cap

JPY 24.09B

RSI (14)

46.6

MomentumView details →

1D Return

−0.33%

YTD Return

−28.52%

ProfitabilityView details →

Gross Margin

50.82%

Net Margin

7.26%

EBITDA Margin

12.84%

ROE (TTM)

13.34%

ROA (TTM)

5.52%

Asset Turnover

0.80x

GrowthView details →

Revenue YoY

−1.91%

EPS YoY

+125.94%

FCF YoY

—

Revenue CAGR 3Y

−17.68%

EPS CAGR 3Y

−24.95%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.91x

Current Ratio

1.03x

Quick Ratio

1.01x

Div Yield

—

Div Rate

—

Div Growth 1Y

+133.33%

Financials snapshotView financials →

Revenue (TTM)

6.79B

Net Income (TTM)

493.00M

Op. CF (TTM)

—

Next earningsNov 16, 2026 →

Latest newsMore news →

Caom Bioscience signed a joint research agreement with Fronteo to create bispecific antibody drugs using AI technology.1d ago

FRONTEO began providing its business data analysis support system 'KIBIT Knowledge Probe' to The 77 Bank.15d ago

Similar companies

User Local,Inc.3984.T OPTiM CORPORATION3694.T Ad-Sol Nissin Corporation3837.T Core Concept Technologies Inc.4371.T TANABE CONSULTING GROUP CO.,LTD.9644.T Focus Systems Corporation4662.T Find similar companies →

Latest newsMore news →

Caom Bioscience signed a joint research agreement with Fronteo to create bispecific antibody drugs using AI technology.1d ago FRONTEO began providing its business data analysis support system 'KIBIT Knowledge Probe' to The 77 Bank.15d ago